Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Daisuke Okajima"'
Autor:
Toshinori Agatsuma, Yuki Abe, Masato Murakami, Yutaka Noguchi, Hirofumi Hamada, Miki Yamaguchi, Shu Takahashi, Riki Goto, Takashi Nakada, Sumie Muramatsu, Tomoko Shibutani, Tomoyo Honda, Tomomichi Fujitani, Reiko Kamei, Michiko Kitamura, Junko Yamaguchi, Tadashi Toki, Tetsuo Aida, Ken Sakurai, Tsuyoshi Karibe, Takanori Maejima, Satoru Yasuda, Daisuke Okajima
Supplementary Data from Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1858eb2b81f8b7c3ad2bbf1d6159d0
https://doi.org/10.1158/1535-7163.22521904
https://doi.org/10.1158/1535-7163.22521904
Autor:
Daisuke Okajima, Satoru Yasuda, Takami Suzuki, Michiko Kitamura, Junko Yamaguchi, Takanori Maejima, Tsuyoshi Karibe, Tadashi Toki, Penny Phillips, Toshinori Agatsuma
Publikováno v:
Cancer Research. 83:2932-2932
Background: Trophoblast cell surface antigen 2 (TROP2) is highly expressed in various epithelial tumors, including non-small cell lung cancer (NSCLC) and triple negative breast cancer (TNBC), and correlates with poor prognosis. Datopotamab deruxtecan
Autor:
Miki Yamaguchi, Reiko Kamei, Ken Sakurai, Tsuyoshi Karibe, Satoru Yasuda, Michiko Kitamura, Daisuke Okajima, Toshinori Agatsuma, Shu Takahashi, Tetsuo Aida, Sumie Muramatsu, Tomomichi Fujitani, Junko Yamaguchi, Hirofumi Hamada, Yutaka Noguchi, Takashi Nakada, Tomoyo Honda, Takanori Maejima, Masato Murakami, Tomoko Shibutani, Riki Goto, Yuki Abe, Tadashi Toki
Publikováno v:
Molecular cancer therapeutics. 20(12)
Trophoblast cell surface antigen 2 (TROP2) is highly expressed on various epithelial tumors and correlates with poor prognosis. We developed the novel TROP2-directed antibody–drug conjugate (ADC), datopotamab deruxtecan (Dato-DXd, DS-1062a), with a
Autor:
Satoru Yasuda, Tomomichi Fujitani, Junko Yamaguchi, Masato Murakami, Tadashi Toki, Tsuyoshi Karibe, Daisuke Okajima, Yutaka Noguchi, Takashi Nakada
Publikováno v:
Molecular Cancer Therapeutics. 18:A027-A027
Background: DS-1062a is a TROP2-targeting antibody-drug conjugate with Daiichi-Sankyo DXd technology. DS-1062a is expected to deliver DXd, a derivative of Exatecan, to TROP2 highly expressed tumors such as epithelial cancers with stronger anti-tumor
Autor:
Reiko Kamei, Daisuke Okajima, Yuki Abe, Tomoko Shibutani, Tomomichi Fujitani, Junko Yamaguchi, Takashi Nakada, Toshinori Agatsuma, Takanori Maejima, Riki Goto, Tadashi Toki, Tsuyoshi Karibe, Yutaka Noguchi, Michiko Kitamura, Satoru Yasuda
Publikováno v:
Molecular Cancer Therapeutics. 18:C026-C026
Background: A trophoblast cell surface antigen 2 (TROP2) is a 36-kDa single-pass transmembrane protein overexpressed in various epithelial tumors including non-small cell lung cancer (NSCLC) with relatively low and restricted expression in normal tis
Autor:
Noboru Yamamoto, Jacob Sands, Alexander I. Spira, Aaron Lisberg, Jonathan Greenberg, Yutaka Noguchi, Edward B. Garon, F. Guevara, Rebecca S. Heist, Toshio Shimizu, Daisuke Okajima, Naoyuki Tajima, Fumiaki Kobayashi
Publikováno v:
Journal of Clinical Oncology. 37:9051-9051
9051 Background: DS-1062a is a trophoblast cell-surface antigen 2 (TROP2)-targeting antibody drug conjugate. TROP2 is highly expressed in epithelial cancers, including non-small cell lung cancer (NSCLC). Overexpression of TROP2 may be associated with
Autor:
Jacob M. Sands, Toshio Shimizu, Edward B. Garon, Jonathan Greenberg, Rebecca Suk Heist, Fumiaki Kobayashi, Yutaka Noguchi, Daisuke Okajima, Alexander I. Spira, Noboru Yamamoto, Tomonari Yamashita, Aaron Elliott Lisberg
Publikováno v:
Journal of Clinical Oncology. 36:TPS2605-TPS2605
Autor:
Tomomichi Fujitani, Junko Yamaguchi, Shinya Tokuhiro, Tomoko Shibutani, Tetsuo Aida, Tadashi Toki, Daisuke Okajima, Ken Sakurai, Satoru Yasuda, Yuki Abe, Toshinori Agatsuma, Yusuke Yokouchi, Tomoko Terauchi, Yutaka Noguchi, Michiko Kitamura, Takashi Nakada
Publikováno v:
Journal of Clinical Oncology. 36:e24206-e24206
e24206Background: DS-1062a is a trophoblast cell surface protein 2 (TROP2)-targeting antibody-drug conjugate (ADC) comprised of a humanized anti-TROP2 monoclonal antibody, enzymatically cleavable p...
Publikováno v:
Journal of Receptors and Signal Transduction. 30:143-153
Brain-specific angiogenesis inhibitor 2 (BAI2) is a member of adhesion-G protein-coupled receptors (GPCRs). BAI2 is dominantly expressed in the brain and its physiological ligands and functions are still unclear. Adhesion-GPCRs, including BAI2, commo
Publikováno v:
PROCEEDINGS OF HYDRAULIC ENGINEERING. 45:37-42
A first priority on crisis management during a natural disaster is to minimize or to mitigate casualties. Therefore refuge information should be transmitted to inhabitants effectively so as to help them understand the situation exactly and to select